Struggling to Breathe: The Patient Journey to Diagnosis and Treatment of Interstitial Lung Disease
This is a 1.25-hour on-demand activity that provides guidance to primary care clinicians who manage care and support for patients with ILDs and their caregivers. The five (5) member faculty is comprised of a primary care physician (PCP), a pulmonologist, an ILD clinical pharmacy specialist, an ILD nurse, and an actual patient with ILD. This multidisciplinary roundtable is delivered as a role-played patient-case through several office visits. The primary care physician interviews an actual ILD patient and consults with the interprofessional team-members on management and best treatment methods. Also included are video vignettes of actual patients to provide the patient's perspective. 
Category
  • Primary Care
Format
  • Self-study / Enduring
Credits
  • 1.00 AAFP Prescribed
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC
  • 1.25 Participation
Alcohol and Pregnancy: The More You Know Season 1
Learn about Prenatal Alcohol Exposure, Fetal Alcohol Spectrum Disorders (FASDs), and how to talk to your patients about unhealthy alcohol use.This 3-part podcast features interviews with a variety of individuals to explore the many facets of FASDs.
Category
  • Addiction Medicine
  • OB/GYN and Women's Health
  • Primary Care
Format
  • Podcast
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Overcoming Barriers to Effective Treatment and Enrollment in Clinical Trials for Black and Underserved Patients with Multiple Myeloma - Focus Group Panel Discussion
Multiple myeloma (MM) is one of the most common hematologic malignancies in adults and is the most common hematologic malignancy in Black patients. The incidence of MM in the black population is 2-3 times higher than in white patients however, the vast majority of MM clinical trials are conducted on a predominantly white population, resulting in a lack of data regarding MM treatment in Black patients. Our panel of expert Hematology/Oncology faculty convene a patient focus group-informed interactive video discussion emphasizing the treatment and clinical research disparities among Black and underserved patients. The focus groups were comprised of diverse groups of MM patients currently being treated at Boston Medical Center. This educational program builds off the complementary enduring activity to further address existing knowledge gaps related to the racial disparities which impact MM therapy and clinical trial inclusion; highlight ongoing inequities; and provide guidance so that healthcare clinicians can more effectively and equitably treat patients with MM. This activity dives into the results of the focus groups via a moderated panel discussion of the interprofessional care team.
Category
  • Hematology/Oncology
Format
  • Self-study / Enduring
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 ANCC
  • 0.75 Participation
Aging Well with HIV: Care Transitions for Older People Living with HIV
This two-module activity addresses the current state of HIV in th
Category
Format
  • Self-study / Enduring
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 ANCC
  • 2.00 Participation
Overcoming Barriers to Effective Treatment and Enrollment in Clinical Trials for Black and Underserved Patients with Multiple Myeloma
Multiple myeloma (MM) is one of the most common hematologic malignancies in adults and is the most common hematologic malignancy in black patients. The incidence of MM in the black population is 2-3 times higher than in white patients however, the vast majority of MM clinical trials are conducted on a predominantly white population, resulting in a lack of data regarding MM treatment in black patients. Our panel of expert Hematology/Oncology faculty convened a patient focus group-informed interactive video discussion emphasizing the treatment and clinical research disparities among black and underserved patients. The focus groups were comprised of diverse groups of MM patients currently being treated at Boston Medical Center. The goals of our educational program are to address existing knowledge gaps related to the racial disparities which impact MM therapy and clinical trial inclusion; highlight ongoing inequities; and provide guidance so that healthcare clinicians can more effectively and equitably treat patients with MM.
Category
  • Hematology/Oncology
Format
  • Self-study / Enduring
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Optimizing Migraine Prevention Through Quality Improvement: Migraine ECHOQI- 3/20/2024
Data Visualization  
Category
Format
Credits
  • 1.00 AAPA Category I Self-assessment
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Event date March 20, 2024
Alzheimer’s Disease Treatments: What’s a PCP to Do? - GIM Grand Rounds 4.10.24
Claiming Credit
Category
Format
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Event date April 10, 2024
Optimizing Migraine Prevention Through Quality Improvement: Migraine ECHOQI- 4/17/2024
Migraine Preventive Treatments- Obtaining Coverage  
Category
Format
Credits
  • 1.00 AAPA Category I Self-assessment
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Event date April 17, 2024
Optimizing Migraine Prevention Through Quality Improvement: Migraine ECHOQI- 5/15/2024
PDSA Check-In 
Category
Format
Credits
  • 1.00 AAPA Category I Self-assessment
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Event date May 15, 2024
Optimizing Migraine Prevention Through Quality Improvement: Migraine ECHOQI- 6/19/2024
Migraine Burden- The Patient Perspective  
Category
Format
Credits
  • 1.00 AAPA Category I Self-assessment
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Participation
Event date June 19, 2024

Pages